Navigation Links
TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
Date:5/26/2009

SAN DIEGO, May 26 /PRNewswire/ -- TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and related diseases, announced today that Phase 1 clinical results from studies of TRC105 and TRC102 in patients with advanced cancer will be presented at the American Society of Clinical Oncology annual meeting this May 28th and 29th in Orlando, Florida. Both programs target unique pathways with the potential for broad application to a wide variety of cancer types.

TRC105 is a monoclonal antibody that binds CD105 (endoglin), a membrane receptor on endothelial cells that is required for angiogenesis. By inhibiting new blood vessel formation, the antibody is expected to have activity against a wide variety of solid tumors that rely on angiogenesis to grow and metastasize. CD105 is also expressed on cancer stem cells.

TRC102 is a small molecule inhibitor of base excision repair that reverses resistance to commonly used antimetabolite and alkylating agent chemotherapies. The molecule is currently being studied as an oral agent in combination with pemetrexed (Alimta(R)) and as an intravenous agent in combination with temozolomide (Temodar(R)).

"TRACON remains on schedule to deliver three Phase 2-ready assets in 2009 including two monoclonal antibodies," commented Charles P. Theuer MD PhD, President and CEO of TRACON Pharmaceuticals. "We are currently engaged in manufacturing and clinical development activities to support comprehensive Phase 2 programs."

The presentation details are as follows:

    TRC105
    Abstract Title: Phase 1 study of TRC105 (anti-CD105 (endoglin) antibody)
    therapy in patients with advanced refractory cancer
    Presenter: Lee Rosen, MD, Premiere Oncology - Los Angeles
    Date and Time: Friday, May 29, 2009, 2:00 PM - 6:00 PM
    Session Title: Developmental Therapeutics
    Session Type: Poster Discussion
    Abst
'/>"/>
SOURCE TRACON Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
2. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
3. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
4. Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
5. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
6. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
7. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
8. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
9. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
10. Transcept Pharmaceuticals to Report First Quarter 2009 Results
11. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Research and Development Trend Forecast of Pharmaceutical Equipment Market ... Research and Development Trend Forecast of Pharmaceutical ... mainly analyzes China,s pharmaceutical equipment ... & demand, competition landscape, and business performance of domestic ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... 29, 2014  In part four of ... hospital pharmacy as a strategic asset, Mary Baxter, ... for Cardinal Health,s Innovation Delivery Solutions business, discusses how ... both hospitals and patients. "Every hospital pharmacist ... of their job in a value-based healthcare world," Baxter ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
... Diamyd Medical AB ( http://www.omxgroup.com, OMX: DIAM B; ... http://www.otcqx.com, ... DIAM B)(OTC: DMYDY)announced today that the Swedish Medical Products,Agency (MPA) ... the therapeutic diabetes vaccine Diamyd(R)., (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ...
... Company Initiates Phase 2a Trial in Patients with Stable Asthma ... Exercise-Induced Bronchoconstriction -, ... clinical program studying an investigational treatment targeting,interleukin-9 (IL-9) has advanced ... The company initiated a Phase 2a clinical trial designed to,assess ...
Cached Medicine Technology:Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe 2MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma 2
(Date:8/31/2014)... 2014 Brook Forest Voices , ... “Simplicity & Sophistication: Short Stories of Wisdom and Kindness ... Dr. James W. Jackson author, speaker, humanitarian and cultural ... compresses his vast volume of meticulously handwritten notes ... 150 countries on behalf of Project C.U.R.E . ...
(Date:8/31/2014)... With the NCAA set to undergo ... an interview with Yale University Associate Athletic Director Steve ... approach to ensuring student-athlete experience that is consistent with ... a number of key factors that contribute to a ... factor in creating this culture seems simple at first. ...
(Date:8/31/2014)... 31 August 2014: Wine only protects against cardiovascular disease ... the In Vino Veritas (IVV) study presented at ESC ... Republic. , Professor Taborsky said: "This is the first ... wine on markers of atherosclerosis (1) in people at ... moderate wine drinking was only protective in people who ...
(Date:8/30/2014)... 2014: A new method to predict the optimal ... presented at ESC Congress today by Dr Benjamin Dahan ... 350 AEDs located in public places for optimal prevention ... Dahan said: "Out of hospital cardiac arrest is a ... between 50 and 100 per 100 000 in the ...
(Date:8/30/2014)... Barcelona, Spain Sunday 31 August 2014: A ... wristwatch and powered by heart motion was presented ... from Switzerland. The prototype device does not require ... in the Cardiovascular Engineering Group at ARTORG, University ... factor in today,s medical implants. Once they reach ...
Breaking Medicine News(10 mins):Health News:Brook Forest Voices Announces End of Summer Release! Dr. James Jackson’s, “Simplicity & Sophistication” Audiobook 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 3Health News:Wine only protects against CVD in people who exercise 2Health News:New method predicts optimal number and location of AEDs 2Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2
... HILLS, Calif., June 11 The Jonsson Cancer,Center ... raising,private funds for highest priority cancer research, hosts ... 21, at the Beverly Wilshire Hotel. FOX,Broadcasting Company ... Humanitarian Award. Jimmy Kimmel hosts the event and ...
... LAUREL, N.J., June 11 MedQuist Inc.,(Pink Sheets: MEDQ.PK). ... the District of New Jersey dismissed the South Broward ... and good cause shown,within 60 days, to reopen the ... in the process of informing the court that the ...
... Institute of Allergy and Infectious Diseases (NIAID), part of the ... George W. Bush with the Presidential Medal of Freedom at ... , The White House noted today that Dr. Fauci ... knowledge. His efforts to advance our understanding and treatment of ...
... PLAINS, NY Experts from throughout the United States will ... the growing crisis of preterm birth. , The conference, ... RADM, USPHS and the Eunice Kennedy Shriver National Institute of ... 16 and 17 in Rockville, MD. It is a ...
... While consumers are increasing demand for pork produced ... such conditions carry bacteria and parasites associated with ... A comparison of swine raised in antibiotic-free and ... outdoors without antibiotics had higher rates of three ...
... some into remission, study says , , WEDNESDAY, June ... golimumab to weekly doses of methotrexate helped most ... into remission, two new studies show. , The ... biologic therapy drug, were scheduled to be presented ...
Cached Medicine News:Health News:American Idol Winner David Cook to Perform at and Jimmy Kimmel to Host Jonsson Cancer Center Foundation's 'Taste for a Cure' on June 21 2Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 2Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 3Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 4Health News:Experts to develop national response to growing crisis of premature birth 2Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 2Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 3Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 4Health News:Golimumab Eases Rheumatoid Arthritis Symptoms 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: